Bexson Biomedical services

We are developing a formulation technology platform & a subcutaneous delivery platform for controlled delivery of critical medications in need of pharmacokinetic innovation.

The US in the midst of an opioid epidemic. Each year millions of people are prescribed these highly addictive therapies to manage post-surgery and chronic pain and the consequences can be deadly.

Bexson’s experienced team has a strong background in health innovation, clinical development and IP creation. Bexson is developing modular subcutaneous delivery platforms for controlled delivery of high value controlled substances and other critical medications in need of pharmacokinetic innovation.